Kola-Pectin DS Interactions
There are 141 drugs known to interact with Kola-Pectin DS (bismuth subsalicylate), along with 2 disease interactions. Of the total drug interactions, 12 are major, 123 are moderate, and 6 are minor.
- View Kola-Pectin DS disease interactions (2)
Medications known to interact with Kola-Pectin DS
Note: Showing generic names only.
A
- abciximab
- acetazolamide
- acetohexamide
- ambenonium
- amlodipine
- anisindione
- apixaban
- ardeparin
- argatroban
- aspirin
B
C
D
- dabigatran
- dalteparin
- danaparoid
- deferasirox
- demeclocycline
- desirudin
- desvenlafaxine
- dexfenfluramine
- dichlorphenamide
- dicumarol
- digitoxin
- digoxin
- diltiazem
- divalproex sodium
- donepezil
- dorzolamide ophthalmic
- doxycycline
- drotrecogin alfa
- duloxetine
E
F
G
H
I
- iloprost
- imipramine
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- isradipine
L
M
- magnesium salicylate
- meperidine
- methadone
- methazolamide
- methotrexate
- milnacipran
- minocycline
- morphine
N
- nalbuphine
- nateglinide
- neostigmine
- niacin
- nicardipine
- nicotinamide
- nifedipine
- nimodipine
- nisoldipine
O
P
R
S
T
V
W
Z
Kola-Pectin DS disease interactions
There are 2 disease interactions with Kola-Pectin DS (bismuth subsalicylate) which include:
Report options
QR code containing a link to this page
More about Kola-Pectin DS (bismuth subsalicylate)
- Kola-Pectin DS consumer information
- Compare alternatives
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: antidiarrheals
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.